Fetal and neonatal outcomes in women reporting ingestion of licorice (Glycyrrhiza uralensis) during pregnancy

Planta Medica

Volumn 79, Issue 2, 2013, Pages 97-101

  Choi, June Seek ^a   Han, Jung Yeol ^a   Ahn, Hyun Kyong ^a   Ryu, Hyun Mee ^a   Kim, Moon Young ^a   Chung, Jin Hoon ^a   Nava Ocampo, Alejandroa ^b,c,d   Koren, Gideon ^c,d  

^a Catholic Kwandong University   (South Korea)

^b PharmaReasons   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Glycyrrhiza uralensis; Leguminosae; licorice; natural products; plant extracts; pregnancy outcomes

Indexed keywords

GLYCYRRHIZA URALENSIS EXTRACT;

ADULT; ALTERNATIVE MEDICINE; ARACHNOID CYST; ARTICLE; CISTERNA MAGNA; COMMON COLD; CONGENITAL MALFORMATION; CONTROLLED STUDY; COUGHING; DRUG INDICATION; FEMALE; FETUS; FETUS ECHOGRAPHY; FETUS OUTCOME; FOOT MALFORMATION; GASTROINTESTINAL DISEASE; GESTATIONAL AGE; HUMAN; HYDROURETER; KIDNEY DYSPLASIA; MAJOR CLINICAL STUDY; MALE; MEGAURETER; NEWBORN; NEWBORN JAUNDICE; OBESITY; OUTCOME ASSESSMENT; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURITY; PRENATAL DRUG EXPOSURE; PROSPECTIVE STUDY; PYELECTASIS; SIDE EFFECT; SOUTH KOREA; STILLBIRTH; TERATOGENICITY; URETEROCELE; VARUS DEFORMITY;

ABNORMALITIES, DRUG-INDUCED; ADULT; CASE-CONTROL STUDIES; COHORT STUDIES; EATING; FEMALE; FETAL DISEASES; FETUS; GESTATIONAL AGE; GLYCYRRHIZA; HERBAL MEDICINE; HUMANS; INFANT, NEWBORN; MALE; NONPRESCRIPTION DRUGS; PREGNANCY; PROSPECTIVE STUDIES; REPUBLIC OF KOREA; RISK FACTORS; STILLBIRTH;

FABACEAE; GLYCYRRHIZA; GLYCYRRHIZA URALENSIS;

EID: 84873059221     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0032-1328102     Document Type: Article

References (21)

1. Asl M. N., Hosseinzadeh H. Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds. Phytother Res: 2008; 22 709 724 (Pubitemid 351955567)
2. Shin S. H., Cho D. H., Jang J. Y., Baek I. J., Yon J. M., Nam S. Y., Yun Y. W., Kim Y. B., Kim S. S., Rhee G. S., Kwack S. J. Effects of licorice on embryonic and fetal development in rats. J Toxicol Pub Health: 2005; 21 325 332
3. Cuzzolin L., Francini-Pesenti F., Verlato G., Joppi M., Baldelli P., Benoni G. Use of herbal products among 392 Italian pregnant women: focus on pregnancy outcome. Pharmacoepidemiol Drug Saf: 2010; 19 1151 1158
4. Strandberg T. E., Järvenpää A. L., Vanhanen H., McKeigue P. M. Birth outcome in relation to licorice consumption during pregnancy. Am J Epidemiol: 2001; 153 1085 1088 (Pubitemid 32493257)
5. Räikkönen K., Pesonen A. K., Heinonen K., Lahti J., Komsi N., Eriksson J. G., Seckl J. R., Järvenpää A. L., Strandberg T. E. Maternal licorice consumption and detrimental cognitive and psychiatric outcomes in children. Am J Epidemiol: 2009; 170 1137 1146
6. Räikkönen K., Seckl J. R., Heinonen K., Pyhälä R., Feldt K., Jones A., Pesonen A. K., Phillips D. I., Lahti J., Järvenpää A. L., Eriksson J. G., Matthews K. A., Strandberg T. E., Kajantie E. Maternal prenatal licorice consumption alters hypothalamic-pituitary-adrenocortical axis function in children. Psychoneuroendocrinology: 2010; 35 1587 1593
7. World Medical Association WMA Declaration of Helsinki - Ethical principles for medical research involving human subjects. 59th WMA General Assembly, Seoul, Korea, October 2008. Available at http://www.wma.net/en/ 30publications/10policies/b3/index.html Accessed October 24, 2012
8. World Health Organization Collaborating Centre for Drug Statistics Methodology Anatomical Therapeutic Chemical (ATC) classification system. Norwegian Institute of Public Health. Oslo, Norway. Available at http://www.whocc.no/atc/structure-and-principles/ Accessed October 24, 2012
9. Strandberg T. E., Andersson S., Järvenpää A. L., McKeigue P. M. Preterm birth and licorice consumption during pregnancy. Am J Epidemiol: 2002; 156 803 805 (Pubitemid 35215760)
10. World Health Organization Neonatal and perinatal mortality: country, regional and global estimates. Available at. http://whqlibdoc.who.int/ publications/2006/9241563206-eng.pdf Accessed October 24, 2012
11. Kamei J., Nakamura R., Ichiki H., Kubo M. Antitussive principles of Glycyrrhizae radix, a main component of the Kampo preparations Bakumondo-to (Mai-men-dong-tang). Eur J Pharmacol: 2003; 469 159 163 (Pubitemid 36629562)
12. Kamei J., Saitoh A., Asano T., Nakamura R., Ichiki H., Iiduka A., Kubo M. Pharmacokinetic and pharmacodynamic profiles of the antitussive principles of Glycyrrhizae radix (licorice), a main component of the Kampo preparation Bakumondo-to (Mai-men-dong-tang). Eur J Pharmacol: 2005; 507 163 168 (Pubitemid 40126852)
13. Fukai T., Satoh K., Nomura T., Sakagami H. Antinephritis and radical scavenging activity of prenylflavonoids. Fitoterapia: 2003; 74 720 724 (Pubitemid 37443466)
14. Fukai T., Satoh K., Nomura T., Sakagami H. Preliminary evaluation of antinephritis and radical scavenging activities of glabridin from Glycyrrhiza glabra. Fitoterapia: 2003; 74 624 629 (Pubitemid 37443449)
15. Niwa K., Hashimoto M., Morishita S., Yokoyama Y., Mori H., Tamaya T. Preventive effects of Glycyrrhizae radix extract on estrogen-related endometrial carcinogenesis in mice. Jpn J Cancer Res: 1999; 90 726 732 (Pubitemid 29381101)
16. Sigurjónsdóttir H. A., Franzson L., Manhem K., Ragnarsson J., Sigurdsson G., Wallerstedt S. Liquorice-induced rise in blood pressure: a linear dose-response relationship. J Hum Hypertens: 2001; 15 549 552 (Pubitemid 32782619)
17. Sigurjonsdottir H. A., Manhem K., Axelson M., Wallerstedt S. Subjects with essential hypertension are more sensitive to the inhibition of 11 beta-HSD by liquorice. J Hum Hypertens: 2003; 17 125 131 (Pubitemid 36292368)
18. Bradley P. British herbal compendium, Volume 2. A handbook of scientific information on widely used plant drugs. Surrey BHMA Publishing: 2006
19. McGuffin M., Hobbs C., Upton R., Goldberg A. American Herbal Products Associations botanical safety handbook. Boca Raton CRC Press LLC: 1997
20. Park D., Yang Y. H., Choi E. K., Yang G., Bae D. K., Lee S. H., Kim T. K., Kyung J., Kim D., Choi K. C., Kim Y. B. Licorice extract increases cyclophosphamide teratogenicity by upregulating the expression of cytochrome P-450 2B mRNA. Birth Defects Res B: 2011; 92 553 559
21. U.S. National Library of Medicine and the National Institutes of Health MedlinePlus. Licorice: copyrighted, evidence-based medicine resource provided by Natural Medicines Comprehensive Database Consumer Version (last reviewed - 07/13/2011). Available at http://www.nlm.nih.gov/medlineplus/druginfo/natural/ 881.html Accessed October 24, 2012